Header Logo

Connection

AJITH NAIR to Humans

Back to Details
This is a "connection" page, showing publications AJITH NAIR has written about Humans.
AJITH NAIR
Connection Strength
0.259
Humans
  1. Management of Dialysis for Patients Receiving Mechanical Circulatory Support. J Am Soc Nephrol. 2026 Mar 01; 37(3):596-606.
    View in: PubMed
    Score: 0.026
  2. Broadening Heart Failure Care Beyond Cardiology: Challenges and Successes Within the Landscape of Multidisciplinary Heart Failure Care. Curr Cardiol Rep. 2023 08; 25(8):851-861.
    View in: PubMed
    Score: 0.022
  3. Myosin Inhibitors: The Next Generation. J Am Coll Cardiol. 2023 01 03; 81(1):46-48.
    View in: PubMed
    Score: 0.021
  4. COVID-19-Associated Fulminant?Myocarditis: Pathophysiology-Related Phenotypic Variance. J Am Coll Cardiol. 2022 07 26; 80(4):313-315.
    View in: PubMed
    Score: 0.021
  5. The Use of Mechanical Circulatory Assist Devices for ACS Patients with Cardiogenic Shock and High-Risk PCI. Curr Cardiol Rep. 2022 06; 24(6):699-709.
    View in: PubMed
    Score: 0.020
  6. Use of Remote Pulmonary Artery Pressure Monitoring (CardioMEMS System) in Total Artificial Heart to Assess Pulmonary Hemodynamics for Heart Transplantation. ASAIO J. 2018 Jul/Aug; 64(4):e75-e77.
    View in: PubMed
    Score: 0.016
  7. Validation of the Prognostic Utility of the Electrocardiogram for Acute Drug Overdose. J Am Heart Assoc. 2017 02 03; 6(2).
    View in: PubMed
    Score: 0.014
  8. Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension. N Engl J Med. 2023 04 20; 388(16):1478-1490.
    View in: PubMed
    Score: 0.011
  9. Aficamten in Obstructive Hypertrophic Cardiomyopathy: A Multidomain, Patient-Level Analysis of the MAPLE-HCM Trial. J Am Coll Cardiol. 2026 Mar 03; 87(8):1029-1042.
    View in: PubMed
    Score: 0.007
  10. Effect of Aficamten vs Metoprolol on Patient-Reported Health Status in Obstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2026 Mar 03; 87(8):1046-1058.
    View in: PubMed
    Score: 0.007
  11. Therapeutic left-to-right shunting in heart failure. Eur Heart J. 2025 May 14; 46(19):1787-1802.
    View in: PubMed
    Score: 0.006
  12. Effect of Preoperative Mitral Regurgitation on LVAD Outcomes in Patients with Elevated Pulmonary Vascular Resistance. Cardiovasc Drugs Ther. 2025 Oct; 39(5):1085-1095.
    View in: PubMed
    Score: 0.006
  13. Sex Disparities in Left Ventricular Assist Device Implantation: Delayed Presentation and Worse Right Heart Failure. ASAIO J. 2024 06 01; 70(6):469-476.
    View in: PubMed
    Score: 0.006
  14. Clinical Predictors and Outcomes After Left Ventricular Assist Device Implantation and Tracheostomy. Tex Heart Inst J. 2023 08 22; 50(4).
    View in: PubMed
    Score: 0.006
  15. Impact of Cancer Care Regionalization on Patient Volume. Ann Surg Oncol. 2023 Apr; 30(4):2331-2338.
    View in: PubMed
    Score: 0.005
  16. Continuous-Flow Ventricular Assist Device Support in Adult Congenital Heart Disease: A 15-Year, Multicenter Experience of Temporary and Durable Support. ASAIO J. 2023 05 01; 69(5):429-437.
    View in: PubMed
    Score: 0.005
  17. Impact of time off anticoagulation in patients with continuous-flow left ventricular assist devices. J Artif Organs. 2023 Dec; 26(4):275-286.
    View in: PubMed
    Score: 0.005
  18. SGLT-2 Inhibitors for Patients with Heart Failure: What Have We Learned Recently? Curr Atheroscler Rep. 2022 08; 24(8):627-634.
    View in: PubMed
    Score: 0.005
  19. The influence of preoperative dialysis on survival after continuous-flow left ventricular assist device implantation. Interact Cardiovasc Thorac Surg. 2022 02 21; 34(3):470-477.
    View in: PubMed
    Score: 0.005
  20. Extracorporeal membrane oxygenation as a bridge to durable left ventricular assist device implantation in INTERMACS-1 patients. J Artif Organs. 2022 Mar; 25(1):16-23.
    View in: PubMed
    Score: 0.005
  21. Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association. Circulation. 2020 07 07; 142(1):e7-e22.
    View in: PubMed
    Score: 0.004
  22. Accuracy of Postoperative Risk Scores for Survival Prediction in Interagency Registry for Mechanically Assisted Circulatory Support Profile 1 Continuous-Flow Left Ventricular Assist Device Recipients. ASAIO J. 2020 05; 66(5):539-546.
    View in: PubMed
    Score: 0.004
  23. Factor Xa inhibitors in patients with continuous-flow left ventricular assist devices. Gen Thorac Cardiovasc Surg. 2020 Nov; 68(11):1278-1284.
    View in: PubMed
    Score: 0.004
  24. Outcomes of Repeat Left Ventricular Assist Device Exchange. ASAIO J. 2020 01; 66(1):64-68.
    View in: PubMed
    Score: 0.004
  25. Acute Kidney Injury With Ventricular Assist Device Placement: National Estimates of Trends and Outcomes. Am J Kidney Dis. 2019 11; 74(5):650-658.
    View in: PubMed
    Score: 0.004
  26. Implantable Ventricular Assist Device Use and Outcomes in People With End-Stage Renal Disease. J Am Heart Assoc. 2018 07 06; 7(14).
    View in: PubMed
    Score: 0.004
  27. Acute kidney injury after implantation of a left ventricular assist device: a comparison of axial-flow (HeartMate II) and centrifugal-flow (HeartWare HVAD) devices. J Artif Organs. 2018 Sep; 21(3):285-292.
    View in: PubMed
    Score: 0.004
  28. ACR appropriateness criteria radiologic management of infected fluid collections. J Am Coll Radiol. 2015 Aug; 12(8):791-9.
    View in: PubMed
    Score: 0.003
  29. Left ventricular assist devices improve functional class without normalizing peak oxygen consumption. ASAIO J. 2015 May-Jun; 61(3):237-43.
    View in: PubMed
    Score: 0.003
  30. Clinical impact of atrial fibrillation in patients with the HeartMate II left ventricular assist device. J Am Coll Cardiol. 2014 Nov 04; 64(18):1883-90.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.